These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21897225)

  • 1. Gastrointestinal defense mechanisms.
    Palileo C; Kaunitz JD
    Curr Opin Gastroenterol; 2011 Oct; 27(6):543-8. PubMed ID: 21897225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroduodenal mucosal defense.
    deFoneska A; Kaunitz JD
    Curr Opin Gastroenterol; 2010 Nov; 26(6):604-10. PubMed ID: 20948371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal defense and cytoprotection: bench to bedside.
    Laine L; Takeuchi K; Tarnawski A
    Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroduodenal mucosal defense.
    Al-Jiboury H; Kaunitz JD
    Curr Opin Gastroenterol; 2012 Nov; 28(6):594-601. PubMed ID: 22954689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Rainsford KD
    Scand J Gastroenterol Suppl; 1989; 163():9-16. PubMed ID: 2683030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroduodenal mucosal defense.
    Ham M; Kaunitz JD
    Curr Opin Gastroenterol; 2008 Nov; 24(6):665-73. PubMed ID: 19122513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sucralfate on gastroduodenal bicarbonate secretion and mucosal prostaglandin E2 metabolism.
    Crampton JR; Gibbons LC; Rees WD
    Scand J Gastroenterol Suppl; 1987; 140():15-8. PubMed ID: 3502196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
    Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic aspects of gastroduodenal mucosa due to NSAIDs.
    Ruina M; Caselli M; Sartori S; Trevisani L; La Corte R; Trotta F; Alvisi V
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():9-11. PubMed ID: 9032574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of gastroduodenal mucosal protection.
    Shorrock CJ; Rees WD
    Am J Med; 1988 Feb; 84(2A):25-34. PubMed ID: 3279766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroduodenal defense.
    Ham M; Kaunitz JD
    Curr Opin Gastroenterol; 2007 Nov; 23(6):607-16. PubMed ID: 17906436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroduodenal mucosal defense.
    Nayeb-Hashemi H; Kaunitz JD
    Curr Opin Gastroenterol; 2009 Nov; 25(6):537-43. PubMed ID: 19654540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.